Searchable abstracts of presentations at key conferences in endocrinology

ea0026p429 | Thyroid (non cancer) | ECE2011

The effect of age on thyroid function and diagnostic significance of TRH test in elderly people

Popovic-Pejicic S P P , Pejicic A P

The effect of age on thyroid function and hypothalamic–pituitary–thyroid axis have been studied. The objective of the study was to examine: correlation between triiodothyronine (T3) and thyroxine (T4) hormone levels, thyroid antibodies and thyroglobulin levels and old age; capability of TSH and prolactin (PRL) response to TRH, in TRH test depending on age and gender of the examines. We have tested 125 subjects, classified in 4 group. First, cont...

ea0026p63 | Endocrine tumours and neoplasia | ECE2011

The influence of different ACTH assays on the ACTH concentrations of patients with small cell lung cancer

Bons J A P , Dingemans A C , Menheere P P C A

Introduction: ACTH is measured to confirm impairments in the hypothalamic–pituitary–adrenal axis. Patients with small cell lung cancer (SCLC) can have ectopic adrenocorticotropic secretion. In December 2009, a SCLC patient showed an enormous discrepancy between the ACTH results obtained with two different ACTH assays. The aim of this study was to compare different ACTH assays in SCLC patients.Methods: In a pilot study EDTA plasma samples of nin...

ea0026p684 | Diabetes therapy | ECE2011

Impact of structured testing on level of glycemic control

Popovic-Pejicic S P P , Karlovic V K

Introduction: Clinical trials have show n that improved glycemic control reduces the incidence and progression of diabetes complications. One of the most important steps in diabetes treatment is to educate patients how to manage self monitorining blood glucose (SBGM) and adjust their life habits with their diabetes. A new diabetes management concept of structured testing is supported by Accu -Chek 360 View.Objectives: Assess the impact of structured test...

ea0026p514 | Bone/calcium/Vitamin D | ECE2011

Secondary hyperparathyroidism in a patient with multiple myeloma

Mandac Rogulj I M R , Radic Kristo D R K , Ostojic Kolonic S O K , Planinc Peraica A P P

Multiple myeloma is a hematologic malignancy characterized by osteolytic bone destruction which follows the increased osteoclastic resorption of bone that is not accompanied by increased bone formation. This can lead to bone pain, diffuse osteopenia, focal lytic lesions, pathologic fractures, spinal cord compression, and hypercalcemia, so it is evident that osteolytic bone disease is a major cause of morbidity and mortality in patients with multiple myeloma. Long-term monthly ...